Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients

The goal of this clinical trial is to learn if an Arabic-language mobile application that uses artificial intelligence (AI) can help women with breast cancer during chemotherapy. The app is designed to give personalized support by reminding participants about their medications, teaching them how to manage treatment side effects, and alerting their healthcare team about serious symptoms. The main questions this study aims to answer are: 1. Does the AI-based mobile app provide accurate and safe recommendations for the patients? 2. Does using the AI-based mobile app help lower treatment-related symptoms and side effects compared to usual care? 3. Does the app help participants take their medications more regularly? 4. Does it increase participants' understanding and satisfaction with the information they receive about their treatment? Researchers will compare two groups: Group 1: Participants who use the AI-based mobile app plus usual oncology care. Group 2: Participants who receive usual care only. Participants will: 1. Use the mobile app daily for 12 weeks while receiving chemotherapy. 2. Complete short questionnaires about symptoms, medication use, and quality of life at the start and end of the study. 3. Report any problems or feedback about using the app. The AI app is for support and education only. It does not make treatment decisions. All information from the app will be reviewed by oncologists and pharmacists to ensure participant safety.

NCT Number	NCT07273812
Lead Sponsor	Dena h. Al-Tameemi Collaborators: Baghdad Medical City
Conditions	Breast Cancer, Breast Neoplasm, Chemotherapy-Related Toxicities, Medication Adherence, Quality of Life in Cancer Patients, Accuracy of AI App, Symptom Management
Enrollment	130 participants
Start Date	2026-06-01
Primary Completion	2026-08-06 (estimated)
Study Completion	2026-11-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-12